ReportWire

Tag: HIV

  • California, other states sue over Trump administration’s latest cuts to HIV programs

    [ad_1]

    California and three other states sued the Trump administration Wednesday over its plans to slash $600 million from programs designed to prevent and track the spread of HIV, including in the LGBTQ+ community — arguing the move is based on “political animus and disagreements about unrelated topics such as federal immigration enforcement, political protest, and clean energy.”

    “This action is lawless,” attorneys for California, Colorado, Illinois and Minnesota said in a complaint filed in federal court in Illinois against President Trump and several of his officials.

    The Centers for Disease Control and Prevention funding had been allocated to disease control programs in all four states, though California Atty. Gen. Rob Bonta’s office said his state faces “the largest share” of the cuts.

    That includes $130 million due to California under a Public Health Infrastructure Block Grant, which the state and its local public health departments use to fund their public health workforce, monitor disease spread and respond to public health emergencies, Bonta’s office said.

    “President Trump … is using federal funding to compel states and jurisdictions to follow his agenda. Those efforts have all previously failed, and we expect that to happen once again,” Bonta said in a statement.

    Health and Human Services Secretary Robert F. Kennedy Jr., one of the named defendants, repeatedly has turned his agency away from evidence-backed HIV monitoring and prevention programs in the last year, and the Trump administration has broadly attacked federal spending headed to blue states or allocated to initiatives geared toward the LGBTQ+ community.

    The White House justified the latest cuts by claiming the programs “promote DEI and radical gender ideology” but did not explain further. Health officials said the cuts were to programs that did not reflect the CDC’s “priorities.”

    Neither the White House nor Health and Human Services immediately responded to requests for comment.

    The Los Angeles County Department of Public Health said the cuts would derail an estimated $64.5 million for 14 county grant programs, resulting in “increased costs, more illness, and preventable deaths,” the department said.

    Those programs focus on response to disasters, controlling outbreaks of diseases such as measles and flu, preventing the spread of diseases such as West Nile, dengue and hepatitis A, monitoring and treating HIV and other sexually transmitted diseases, fighting chronic illnesses such as diabetes and obesity, and supporting community health, the department said.

    Those cuts also would include about $1.1 million for the department’s National HIV Behavioral Surveillance Project, which is focused on detecting emerging HIV trends and preventing outbreaks.

    Dr. Paul Simon, an epidemiologist at the UCLA Fielding School and former chief science officer for the county’s public health department, said slashing the program was a “dangerous” and “shortsighted” move that would leave public health officials in the dark as to what’s happening with the disease on the ground.

    Considerable cuts also are anticipated to the City of Long Beach, UCLA and nine community health providers who provide HIV prevention services, including $383,000 for the Los Angeles LGBT Center’s community HIV prevention programs, local officials said.

    Leading California Democrats railed against the cuts. Sen. Alex Padilla (D-Calif.) said the move was an unlawful attempt by Trump to punish blue states that “won’t bend to his extremist agenda.”

    “His message to the 1.2 million Americans living with HIV is clear: their lives are not a priority, political retribution is,” Padilla said in a statement.

    The states argue in the lawsuit that the administration’s decision “singles out jurisdictions for disfavor based not on any rational purpose related to the goals of any program but rather based on partisan animus.”

    The lawsuit asked the court to declare the cuts unlawful and to bar the administration from implementing them or “engaging in future retaliatory conduct regarding federal funding or other participation in federal programs” based on the states exercising their sovereign authority in unrelated matters.

    [ad_2]

    Kevin Rector, Gavin J. Quinton

    Source link

  • LGBTQ+ community calls out Radio Korea over host’s homophobic comments; station acknowledges but skirts accountability

    [ad_1]

    You may not be too familiar with LA County Assessor Jeffrey Prang. You’ve probably never heard of the office of the LA County Assessor, or you might only have a vague notion of what it does.

    But with a career in city politics spanning nearly thirty years, he’s among the longest-serving openly gay elected officials in the United States, and for his work serving the people of Los Angeles and championing the rights of the city’s LGBTQ people, the Stonewall Democratic Club is honoring him at their 50th Anniversary Celebration and Awards Night Nov 15 at Beaches Tropicana in West Hollywood.

    Prang moved to Los Angeles from his native Michigan after college in 1991, specifically seeking an opportunity to serve in politics as an openly gay man. In 1997, he was elected to the West Hollywood City Council, where he served for 18 years, including four stints as mayor.

    “I was active in politics, but in Michigan at the time I left, you couldn’t really be out and involved in politics… My life was so compartmentalized. I had my straight friends, my gay friends, my political friends, and I couldn’t really mix and match those things,” he says.

    “One of the things that was really impactful was as you drove down Santa Monica Boulevard and saw those rainbow flags placed there by the government in the median island. That really said, this is a place where you can be yourself. You don’t have to be afraid.” 

    One thing that’s changed over Prang’s time in office is West Hollywood’s uniqueness as a place of safety for the queer community. 

    “It used to be, you could only be out and gay and politically involved if you were from Silver Lake or from West Hollywood. The thought of being able to do that in Downey or Monterey Park or Pomona was foreign. But now we have LGBTQ centers, gay pride celebrations, and LGBT elected officials in all those jurisdictions, something that we wouldn’t have thought possible 40 years ago,” he says.

    Prang’s jump to county politics is emblematic of that shift. In 2014, amid a scandal that brought down the previous county assessor, Prang threw his name in contention for the job, having worked in the assessor’s office already for the previous two years. He beat out eleven contenders in the election, won reelection in 2018 and 2022, and is seeking a fourth term next year.

    To put those victories in perspective, at the time of his first election, Prang represented more people than any other openly gay elected official in the world. 

    Beyond his office, Prang has lent his experience with ballot box success to helping get more LGBT people elected through his work with the Stonewall Democrats and with a new organization he co-founded last year called the LA County LGBTQ Elected Officials Association (LACLEO).

    LACLEO counts more than fifty members, including officials from all parts of the county, municipal and state legislators, and members of school boards, water boards, and city clerks.  

    “I assembled this group to collectively use our elected strength and influence to help impact policy in Sacramento and in Washington, DC, to take advantage of these elected leaders who have a bigger voice in government than the average person, and to train them and educate them to be better advocates on behalf of the issues that are important for us,” Prang says.

    “I do believe as a senior high-level official I need to play a role and have an important voice in supporting our community,” he says. 

    Ok, but what is the LA County assessor, anyway? 

    “Nobody knows what the assessor is. 99% of people think I’m the guy who collects taxes,” Prang says.

    The assessor makes sure that all properties in the county are properly recorded and fairly assessed so that taxes can be levied correctly. It’s a wonky job, but one that has a big impact on how the city raises money for programs.

    And that wonkiness suits Prang just fine. While the job may seem unglamorous, he gleefully boasts about his work overhauling the office’s technology to improve customer service and efficiency, which he says is proving to be a role model for other county offices.

    “I inherited this 1970s-era mainframe green screen DOS-based legacy system. And believe it or not, that’s the standard technology for most large government agencies. That’s why the DMV sucks. That’s why the tax collection system sucks. But I spent $130 million over almost 10 years to rebuild our system to a digitized cloud-based system,” Prang says.

    “I think the fact that my program was so successful did give some impetus to the board funding the tax collector and the auditor-controller to update their system, which is 40 years behind where they need to be.”

    More tangible impacts for everyday Angelenos include his outreach to promote tax savings programs for homeowners, seniors, and nonprofits, and a new college training program that gives students a pipeline to good jobs in the county.

    As attacks on the queer community intensify from the federal government, Prang says the Stonewall Democrats are an important locus of organization and resistance, and he encourages anyone to get involved.

    “It is still an important and relevant organization that provides opportunities for LGBTQ people to get involved, to have an impact on our government and our civic life. If you just wanna come and volunteer and donate your time, it provides that, if you really want to do more and have a bigger voice and move into areas of leadership, it provides an opportunity for that as well,” he says.

    [ad_2]

    Kristie Song

    Source link

  • 41st AIDS Walk LA steps out with “Community Is the Cure” message

    [ad_1]

    Thousands gathered Sunday at West Hollywood Park for the 41st annual AIDS Walk Los Angeles.

    This year’s theme, “Community is the Cure,” was meant to reflect a sobering reality: the fight against HIV is not over, and the community must once again lead the way.

    Founded in 1985 as a response to government inaction, AIDS Walk Los Angeles continues to raise critical funds for APLA Health, which provides comprehensive services to more than 22,000 Angelenos each year, with a strong focus on people with or at risk for HIV.

    Team ABC7 | Disney PRIDE shows their spirit at AIDS Walk Los Angeles

    Support ABC7 & Disney PRIDE’s AIDS Walk Team by purchasing merchandise from the ABC7 Pride collection!

    These include access to free and low-cost HIV medical care, PrEP and PEP, testing, case management, benefits counseling, mental health services, and the nation’s largest food pantry for people living with HIV.

    “This event was born out of urgency, and it’s just as relevant today,” said Craig E. Thompson, CEO of APLA Health. “We’ve made incredible progress in the fight against HIV, but that progress is under direct threat from funding cuts and political attacks.”

    While scientific advances like U=U (Undetectable = Untransmittable) and PrEP have transformed HIV prevention and treatment, organizers say too many people still face barriers to accessing the care they need.

    “We’re being pushed back-but we’re still facing forward,” said Thompson. “AIDS Walk is how we protect each other, amplify our voices, and keep moving forward, together.”

    Participants in the 41st AIDS Walk LA tell us why they walk

    This year’s opening ceremony was hosted by ABC7’s Coleen Sullivan, and featured speakers U.S. Rep. Maxine Waters, West Hollywood Mayor Chelsea Lee Byers and L.A. County Supervisor Lindsey P. Horvath among others, as well as a special live performance by Heidi N Closet, star of RuPaul’s Drag Race, who was introduced by fellow Drag Race alum Monét X Change.

    For more information, visit aidswalk.la.

    Copyright © 2025 KABC Television, LLC. All rights reserved.

    [ad_2]

    KABC

    Source link

  • Fred Says Foundation Announces Its 2024 Gifts for World AIDS Day

    [ad_1]

    On December 1st, the Fred Says Foundation gave $215,000 to 11 youth-serving organizations to support LGBTQ young people and youth living with and/or impacted by HIV.

    As it has done for more than a decade, on December 1st, World AIDS Day, the Fred Says Foundation announced its 2024 giving to youth-serving organizations in the United States and around the world.

    Founded in 2013 by Dr. Robert Garofalo and his dog, Fred, Fred Says is a non-profit charity supporting U.S. and international organizations that care for or provide services to LGBTQ young people and youth living with and/or impacted by HIV. Dr. Garofalo is the Chief of the Division of Adolescent & Young Adult Medicine at Ann & Robert H. Lurie Children’s Hospital in Chicago and Professor of Pediatrics at Northwestern University’s Feinberg School of Medicine. Dr. Garofalo adopted Fred after his own HIV diagnosis. Fred Says honors the relationship with his dog that created space in his life for healing and raises awareness and funds for young people affected by HIV.

    “On World AIDS Day we honor those we have lost, celebrate amazing advances in treatment and prevention, and recommit ourselves to the resolve needed to end this pandemic,” said Garofalo. “Fred Says is proud to be part of those efforts helping organizations provide the care and services young people need to thrive as their best authentic selves.”

    In sum, $215,000 will be gifted to 11 youth-serving organizations to support a range of services including: pet therapy and adoption programs, specialized mental health and drop-in services, transportation and housing assistance, peer-led support for transgender and HIV+ youth, and HIV-prevention efforts both in the U.S. and Sub-Saharan Africa.

    The 2024 Fred Says award recipients are:

    Fred Says also continues its annual tradition of distributing 500 Fred plush toys to children for the holidays in Chicago and Birmingham as well as in Nigeria and South Africa.

    “Magic City Acceptance Academy (MCAA), a grade 6-12 public charter school in Birmingham, Alabama, empowers students to embrace education and achieve individual success in a brave, LGBTQ-affirming environment,” said Karen Musgrove CEO of MCAA and Birmingham AIDS Outreach. “We are so grateful for the generous and ongoing support of Fred Says which allows us to provide the vital mental health and social support services that are the foundation of our students’ success.”

    Learn more about Fred Says at www.fredsays.org.

    Source: Fred Says Foundation

    [ad_2]

    Source link

  • 40th anniversary AIDS Walk happening this weekend in West Hollywood

    40th anniversary AIDS Walk happening this weekend in West Hollywood

    [ad_1]

    Four months after seeking asylum in the U.S., Fernando Hermida began coughing and feeling tired. He thought it was a cold. Then sores appeared in his groin and he would soak his bed with sweat. He took a test.

    On New Year’s Day 2022, at age 31, Hermida learned he had HIV.

    “I thought I was going to die,” he said, recalling how a chill washed over him as he reviewed his results. He struggled to navigate a new, convoluted health care system. Through an HIV organization he found online, he received a list of medical providers to call in D.C., where he was at the time, but they didn’t return his calls for weeks. Hermida, who speaks only Spanish, didn’t know where to turn.

    By the time of Hermida’s diagnosis, the U.S. Department of Health and Human Services was about three years into a federal initiative to end the nation’s HIV epidemic by pumping hundreds of millions of dollars annually into certain states, counties, and U.S. territories with the highest infection rates. The goal was to reach the estimated 1.2 million people living with HIV, including some who don’t know they have the disease.

    Overall, estimated new HIV infection rates declined 23 percent from 2012 to 2022. But a KFF Health News-Associated Press analysis found the rate has not fallen for Latinos as much as it has for other racial and ethnic groups.

    While African Americans continue to have the highest HIV rates in the U.S. overall, Latinos made up the largest share of new HIV diagnoses and infections among gay and bisexual men in 2022, per the most recent data available, compared with other racial and ethnic groups. Latinos, who make up about 19 percent of the U.S. population, accounted for about 33 percent of new HIV infections, according to the Centers for Disease Control and Prevention.

    The analysis found Latinos are experiencing a disproportionate number of new infections and diagnoses across the U.S., with diagnosis rates highest in the Southeast. Public health officials in Mecklenburg County, North Carolina, and Shelby County, Tennessee, where data shows diagnosis rates have gone up among Latinos, told KFF Health News and the AP that they either don’t have specific plans to address HIV in this population or that plans are still in the works. Even in well-resourced places like San Francisco, HIV diagnosis rates grew among Latinos in the last few years while falling among other racial and ethnic groups despite the county’s goals to reduce infections among Latinos.

    “HIV disparities are not inevitable,” Robyn Neblett Fanfair, director of the CDC’s Division of HIV Prevention, said in a statement. She noted the systemic, cultural, and economic inequities — such as racism, language differences, and medical mistrust.

    And though the CDC provides some funds for minority groups, Latino health policy advocates want HHS to declare a public health emergency in hopes of directing more money to Latino communities, saying current efforts aren’t enough.

    “Our invisibility is no longer tolerable,” said Vincent Guilamo-Ramos, co-chair of the Presidential Advisory Council on HIV/AIDS.

    Lost without an interpreter

    Hermida suspects he contracted the virus while he was in an open relationship with a male partner before he came to the U.S. In late January 2022, months after his symptoms started, he went to a clinic in New York City that a friend had helped him find to finally get treatment for HIV.

    Too sick to care for himself alone, Hermida eventually moved to Charlotte to be closer to family and in hopes of receiving more consistent health care. He enrolled in an Amity Medical Group clinic that receives funding from the Ryan White HIV/AIDS Program, a federal safety-net plan that serves over half of those in the nation diagnosed with HIV, regardless of their citizenship status.

    His HIV became undetectable after he was connected with case managers. But over time, communication with the clinic grew less frequent, he said, and he didn’t get regular interpretation help during visits with his English-speaking doctor. An Amity Medical Group representative confirmed Hermida was a client but didn’t answer questions about his experience at the clinic.

    Hermida said he had a hard time filling out paperwork to stay enrolled in the Ryan White program, and when his eligibility expired in September 2023, he couldn’t get his medication.

    He left the clinic and enrolled in a health plan through the Affordable Care Act marketplace. But Hermida didn’t realize the insurer required him to pay for a share of his HIV treatment.

    In January, the Lyft driver received a $1,275 bill for his antiretroviral — the equivalent of 120 rides, he said. He paid the bill with a coupon he found online. In April, he got a second bill he couldn’t afford.

    For two weeks, he stopped taking the medication that keeps the virus undetectable and intransmissible.

    “Estoy que colapso,” he said. I’m falling apart. “Tengo que vivir para pagar la medicación.” I have to live to pay for my medication.

    One way to prevent HIV is preexposure prophylaxis, or PrEP, which is regularly taken to reduce the risk of getting HIV through sex or intravenous drug use. It was approved by the federal government in 2012 but the uptake has not been even across racial and ethnic groups: CDC data show much lower rates of PrEP coverage among Latinos than among white Americans.

    Epidemiologists say high PrEP use and consistent access to treatment are necessary to build community-level resistance.

    Carlos Saldana, an infectious disease specialist and former medical adviser for Georgia’s health department, helped identify five clusters of rapid HIV transmission involving about 40 gay Latinos and men who have sex with men from February 2021 to June 2022. Many people in the cluster told researchers they had not taken PrEP and struggled to understand the health care system.

    They experienced other barriers, too, Saldana said, including lack of transportation and fear of deportation if they sought treatment.

    Latino health policy advocates want the federal government to redistribute funding for HIV prevention, including testing and access to PrEP. Of the nearly $30 billion in federal money that went toward things like HIV health care services, treatment, and prevention in 2022, only 4% went to prevention, according to a KFF analysis.

    They suggest more money could help reach Latino communities through efforts like faith-based outreach at churches, testing at clubs on Latin nights, and training bilingual HIV testers.

    Latino rates going up

    Congress has appropriated $2.3 billion over five years to the Ending the HIV Epidemic initiative, and jurisdictions that get the money are to invest 25 percent of it in community-based organizations. But the initiative lacks requirements to target any particular groups, including Latinos, leaving it up to the cities, counties, and states to come up with specific strategies.

    In 34 of the 57 areas getting the money, cases are going the wrong way: Diagnosis rates among Latinos increased from 2019 to 2022 while declining for other racial and ethnic groups, the KFF Health News-AP analysis found.

    Starting Aug. 1, state and local health departments will have to provide annual spending reports on funding in places that account for 30 percent or more of HIV diagnoses, the CDC said. Previously, it had been required for only a small number of states.

    In some states and counties, initiative funding has not been enough to cover the needs of Latinos.

    South Carolina, which saw rates nearly double for Latinos from 2012-2022, hasn’t expanded HIV mobile testing in rural areas, where the need is high among Latinos, said Tony Price, HIV program manager in the state health department. South Carolina can pay for only four community health workers focused on HIV outreach — and not all of them are bilingual.

    In Shelby County, Tennessee, home to Memphis, the Latino HIV diagnosis rate rose 86 percent from 2012 to 2022. The health department said it got $2 million in initiative funding in 2023 and while the county plan acknowledges that Latinos are a target group, department director Michelle Taylor said: “There are no specific campaigns just among Latino people.”

    Up to now, Mecklenburg County, North Carolina, didn’t include specific targets to address HIV in the Latino population — where rates of new diagnoses more than doubled in a decade but fell slightly among other racial and ethnic groups. The health department has used funding for bilingual marketing campaigns and awareness about PrEP.

    Moving for medicine

    When it was time to pack up and move to Hermida’s third city in two years, his fiancé, who is taking PrEP, suggested seeking care in Orlando, Fla.

    The couple, who were friends in high school in Venezuela, had some family and friends in Florida, and they had heard about Pineapple Healthcare, a nonprofit primary care clinic dedicated to supporting Latinos living with HIV.

    The clinic is housed in a medical office south of downtown Orlando. Inside, the mostly Latino staff is dressed in pineapple-print turquoise shirts, and Spanish, not English, is most commonly heard in appointment rooms and hallways.

    “At the core of it, if the organization is not led by and for people of color, then we’re just an afterthought,” said Andres Acosta Ardila, the community outreach director at Pineapple Healthcare, who was diagnosed with HIV in 2013.

    “¿Te mudaste reciente, ya por fin?” asked nurse practitioner Eliza Otero. Did you finally move? She started treating Hermida while he still lived in Charlotte. “Hace un mes que no nos vemos.” It’s been a month since we last saw each other.

    They still need to work on lowering his cholesterol and blood pressure, she told him. Though his viral load remains high, Otero said it should improve with regular, consistent care.

    Pineapple Healthcare, which doesn’t receive initiative money, offers full-scope primary care to mostly Latino males. Hermida gets his HIV medication at no cost there because the clinic is part of a federal drug discount program.

    The clinic is in many ways an oasis. The new diagnosis rate for Latinos in Orange County, Florida, which includes Orlando, rose by about a third from 2012 through 2022, while dropping by a third for others. Florida has the third-largest Latino population in the U.S., and had the seventh-highest rate of new HIV diagnoses among Latinos in the nation in 2022.

    Hermida, whose asylum case is pending, never imagined getting medication would be so difficult, he said during the 500-mile drive from North Carolina to Florida. After hotel rooms, jobs lost, and family goodbyes, he is hopeful his search for consistent HIV treatment — which has come to define his life the past two years — can finally come to an end.

    “Soy un nómada a la fuerza, pero bueno, como me comenta mi prometido y mis familiares, yo tengo que estar donde me den buenos servicios médicos,” he said. I’m forced to be a nomad, but like my family and my fiancé say, I have to be where I can get good medical services.

    That’s the priority, he said. “Esa es la prioridad ahora.”

    KFF Health News and The Associated Press analyzed data from the U.S. Centers for Disease Control and Prevention on the number of new HIV diagnoses and infections among Americans ages 13 and older at the local, state, and national levels. This story primarily uses incidence rate data — estimates of new infections — at the national level and diagnosis rate data at the state and county level.

    Bose reported from Orlando, Fla.. Reese reported from Sacramento, Calif. AP video journalist Laura Bargfeld contributed to this report.

    The Associated Press Health and Science Department receives support from the Robert Wood Johnson Foundation. The AP is responsible for all content.

    This article was produced by KFF Health News, which publishes California Healthline, an editorially independent service of the California Health Care Foundation.

    A Project of KFF Health News and the Associated Press co-published by Univision Noticias

    CREDITS:

    Reporters: Vanessa G. Sánchez, Devna Bose, Phillip Reese

    Cinematography: Laura Bargfeld

    Photography: Laura Bargfeld, Phelan M. Ebenhack

    Video Editing: Federica Narancio, Kathy Young, Esther Poveda

    Additional Video: Federica Narancio, Esther Poveda

    Web Production: Eric Harkleroad, Lydia Zuraw

    Special thanks to Lindsey Dawson

    Editors: Judy Lin, Erica Hunzinger

    Data Editor: Holly Hacker

    Social Media: Patricia Vélez, Federica Narancio, Esther Poveda, Carolina Astuya, Natalia Bravo, Juan Pablo Vargas, Kyle Viterbo, Sophia Eppolito, Hannah Norman, Chaseedaw Giles, Tarena Lofton

    Translation: Paula Andalo

    Copy Editing: Gabe Brison-Trezise

    KFF Health News is a national newsroom that produces in-depth journalism about health issues and is one of the core operating programs at KFF — an independent source of health policy research, polling, and journalism. Learn more about KFF.

    Subscribe to KFF Health News’ free Morning Briefing.

    [ad_2]

    Gisselle Palomera

    Source link

  • HIV-positive sex workers no longer required to register as violent sex offenders in Tennessee

    HIV-positive sex workers no longer required to register as violent sex offenders in Tennessee

    [ad_1]

    Since 2010, HIV-positive sex workers in Tennessee have been required to register for life on the state’s sex offender registry. However, under a lawsuit settlement released last week, Tennessee officials have agreed to reverse course and begin notifying affected individuals that they can now be removed from the registry. 

    In 1991, Tennessee passed an “aggravated prostitution” law, making it a felony to sell sex while being knowingly HIV-positive. In 1995, when the state introduced a sex offender registry, those convicted of aggravated prostitution were forced to register. However, things got worse in 2010, when the crime was reclassified as a “violent sexual offense,” meaning that those convicted would face lifetime registration.

    Last year, the American Civil Liberties Union (ACLU) filed a lawsuit against the state of Tennessee, arguing that the law unfairly targeted HIV-positive individuals, who are classified as having a disability under the Americans with Disabilities Act.

    “Unlike Prostitution, which is a misdemeanor, Aggravated Prostitution is a felony that requires lifetime registration as a ‘violent sex offender,’” the complaint states. “This drastic difference in treatment turns solely on HIV status and is so unmoored from medical facts as to punish sexual encounters that pose no risk of HIV transmission.”

    Being placed on a sex offender registry makes finding employment and housing incredibly difficult. Even though “aggravated prostitution” refers to consensual sex between adults, affected registrants are barred from working or living within 1,000 feet of a school, playground, or park, in addition to other onerous restrictions.

    “There are many other chronic and manageable infectious conditions prevalent in Tennessee, but none are subject to such draconian and counterproductive punishment,” the complaint states. “That individuals living with HIV are treated so differently can only be understood as a remnant of the profoundly prejudiced early response to the AIDS epidemic.”

    In February, Tennessee legislators voted to remove aggravated prostitution from the state’s definition of “sexual offense” or “violent sexual offense,” and allow affected individuals to apply for removal. That change went into effect at the start of this month. However, as part of a lawsuit settlement reached last week, Tennessee officials will take an additional step: They will send letters informing individuals placed on the registry for HIV-positive sex work that they can now request to have their names removed.

    Unfortunately, neither the settlement nor the legislature’s changes to Tennesee law remove aggravated prostitution as a crime altogether.

    “This settlement is one step towards remedying those harms by addressing the sex offender registration,” attorneys from the ACLU and the Transgender Law Center in a statement said in a statement obtained by the Associated Press. “However, as aggravated prostitution remains a felony, our legal team will continue to fight to overturn this statute and ensure that no one in Tennessee is criminalized based on their health status.”

    [ad_2]

    Emma Camp

    Source link

  • Historic low HIV infection rates in New York

    Historic low HIV infection rates in New York

    [ad_1]

    CAPITAL REGION, N.Y. (NEWS10) — June 27 is National HIV testing day, and the New York State Department of Health says New York is at an all-time low of new infection rates. NEWS10 speaking with a local group on their efforts here in the capital region to help eradicate the disease.

    New York has hit historic lows in HIV new infection rates since the pandemic’s height in the 1990s. However local HIV specialists say now is not the time to relax.

    “The battle is not over. There are places and populations that are increasing in rates of infection, and we need to get those individuals identified and we need to help them get into the care that they need. Because there are things that we can do now that’ll make life normal and long lived,” said Kim Atkins, Executive Director Alliance for Positive Health.

    New York’s new infection rates have plummeted 42% since 2011 from nearly 4000 new infections a year down to just over 2000 a year in 2022. 18% of new infections tested positive for AIDS and 69% of new infection rate diagnoses are people under the age of 40. 

    The Alliance for Positive Health has been providing free testing for nearly 40 years. “Testing needs to continue, and we need to identify people because people are still getting infected,” said Atkins.

    And now, the Alliance for Positive Health teams can get to more people in further away places with their new mobility fleet.  “This is the newer one we have a larger one that we could test two people at once. Recover 15 counties so we go all the way up to Plattsburgh and all the way down to Hudson and anywhere in between,” said Testing Supervisor Alliance for Positive Health, Niurka Diaz Gonzalez.

    Chris Francis has been with the Alliance team for over 10 years and is part of the Care Coordination. He tells NEWS10 Reporter James De La Fuente about the importance of testing.

    “I suggest people get tested every couple, of every two to three months. Especially if they’re sexually active.” Francis says testing is personal. “I care about my physical and mental health. It can take a toll on your mental health if you don’t get tested not knowing what you have or if you’re clean.”

    As black and brown communities are adversely affected Chandler Hickenbottom, co-founder of Saratoga BLM says her organization is taking focus on testing, as well.

    “As of right now we don’t have anything posted. But I think that is something that after having this conversation, I think it would be really great and important for us to start getting more involved in. So, joining the campaign to show the importance of not just getting tested in general, not just even for HIV, but for all sexually transmitted infections and STD’s. That is definitely very important,” said Hickenbottom.

    A spokesperson with NYDOH says, “HIV in New York State has fallen to historic lows. At its peak in the mid-1990s, New York diagnosed nearly 15,000 new cases per year; that number was down to 2,318 in 2022.”

    In addition to testing with Alliance for Positive Health, the New York State Department of Health Aids Institute has announced the launch of their free HIV self-test giveaway.

    [ad_2]

    James De La Fuente

    Source link

  • There’s New Hope for an HIV Vaccine

    There’s New Hope for an HIV Vaccine

    [ad_1]

    Since it was first identified in 1983, HIV has infected more than 85 million people and caused some 40 million deaths worldwide.

    While medication known as pre-exposure prophylaxis, or PrEP, can significantly reduce the risk of getting HIV, it has to be taken every day to be effective. A vaccine to provide lasting protection has eluded researchers for decades. Now, there may finally be a viable strategy for making one.

    An experimental vaccine developed at Duke University triggered an elusive type of broadly neutralizing antibody in a small group of people enrolled in a 2019 clinical trial. The findings were published today in the scientific journal Cell.

    “This is one of the most pivotal studies in the HIV vaccine field to date,” says Glenda Gray, an HIV expert and the president and CEO of the South African Medical Research Council, who was not involved in the study.

    A few years ago, a team from Scripps Research and the International AIDS Vaccine Initiative (IAVI) showed that it was possible to stimulate the precursor cells needed to make these rare antibodies in people. The Duke study goes a step further to generate these antibodies, albeit at low levels.

    “This is a scientific feat and gives the field great hope that one can construct an HIV vaccine regimen that directs the immune response along a path that is required for protection,” Gray says.

    Vaccines work by training the immune system to recognize a virus or other pathogen. They introduce something that looks like the virus—a piece of it, for example, or a weakened version of it—and by doing so, spur the body’s B cells into producing protective antibodies against it. Those antibodies stick around so that when a person later encounters the real virus, the immune system remembers and is poised to attack.

    While researchers were able to produce Covid-19 vaccines in a matter of months, creating a vaccine against HIV has proven much more challenging. The problem is the unique nature of the virus. HIV mutates rapidly, meaning it can quickly outmaneuver immune defenses. It also integrates into the human genome within a few days of exposure, hiding out from the immune system.

    “Parts of the virus look like our own cells, and we don’t like to make antibodies against our own selves,” says Barton Haynes, director of the Duke Human Vaccine Institute and one of the authors on the paper.

    The particular antibodies that researchers are interested in are known as broadly neutralizing antibodies, which can recognize and block different versions of the virus. Because of HIV’s shape-shifting nature, there are two main types of HIV and each has several strains. An effective vaccine will need to target many of them.

    Some HIV-infected individuals generate broadly neutralizing antibodies, although it often takes years of living with HIV to do so, Haynes says. Even then, people don’t make enough of them to fight off the virus. These special antibodies are made by unusual B cells that are loaded with mutations they’ve acquired over time in reaction to the virus changing inside the body. “These are weird antibodies,” Haynes says. “The body doesn’t make them easily.”

    [ad_2]

    Emily Mullin

    Source link

  • DNA of North Texas Serial Rapist With HIV Tied To Another Sexual Assault

    DNA of North Texas Serial Rapist With HIV Tied To Another Sexual Assault

    [ad_1]

    A Denton County resident already sitting in jail with multiple charges now faces another sexual assault charge after DNA evidence linked him to a 2022 rape, according to Denton police. “In February 2024, Carrollton Police Department detectives notified Denton PD that they had identified and arrested a suspect in similar sexual assault cases in their city,” a press release stated…

    [ad_2]

    Kelly Dearmore

    Source link

  • CDC says it’s identified 1st documented cases of HIV transmitted through cosmetic needles

    CDC says it’s identified 1st documented cases of HIV transmitted through cosmetic needles

    [ad_1]

    Three women who were diagnosed with HIV after getting “vampire facial” procedures at an unlicensed New Mexico medical spa are believed to be the first documented cases of people contracting the virus through a cosmetic procedure using needles, federal health officials said.The Centers for Disease Control and Prevention said in its Morbidity and Mortality Report last week that an investigation into the clinic from 2018 through 2023 showed it apparently reused disposable equipment intended for one-time use.Although HIV transmission from contaminated blood through unsterile injection is a well-known risk, the report said this is the first documentation of probable infections involving cosmetic services.Many popular cosmetic treatments are delivered with needles, such as Botox to iron out wrinkles and fillers to plump lips. A “vampire facial,” or platelet-rich plasma microneedling procedure, involves drawing a client’s own blood, separating its components, then using tiny needles to inject plasma into the face to rejuvenate the skin. Tattoos also require needles.The New Mexico Department of Health began investigating the spa in the summer of 2018 after it was notified that a woman in her 40s had tested positive for HIV even though she had no known risk factors. The woman reported exposure to needles through the procedure at the clinic that spring.The spa closed in fall 2018 after the investigation was launched, and its owner was prosecuted for practicing medicine without a license.The report said the investigation showed how important it is to require infection control practices at businesses that offer cosmetic procedures involving needles.It also noted that the investigation was slowed by poor record keeping and said businesses providing such services should keep better records in case clients need to be contacted later.

    Three women who were diagnosed with HIV after getting “vampire facial” procedures at an unlicensed New Mexico medical spa are believed to be the first documented cases of people contracting the virus through a cosmetic procedure using needles, federal health officials said.

    The Centers for Disease Control and Prevention said in its Morbidity and Mortality Report last week that an investigation into the clinic from 2018 through 2023 showed it apparently reused disposable equipment intended for one-time use.

    Although HIV transmission from contaminated blood through unsterile injection is a well-known risk, the report said this is the first documentation of probable infections involving cosmetic services.

    Many popular cosmetic treatments are delivered with needles, such as Botox to iron out wrinkles and fillers to plump lips. A “vampire facial,” or platelet-rich plasma microneedling procedure, involves drawing a client’s own blood, separating its components, then using tiny needles to inject plasma into the face to rejuvenate the skin. Tattoos also require needles.

    The New Mexico Department of Health began investigating the spa in the summer of 2018 after it was notified that a woman in her 40s had tested positive for HIV even though she had no known risk factors. The woman reported exposure to needles through the procedure at the clinic that spring.

    The spa closed in fall 2018 after the investigation was launched, and its owner was prosecuted for practicing medicine without a license.

    The report said the investigation showed how important it is to require infection control practices at businesses that offer cosmetic procedures involving needles.

    It also noted that the investigation was slowed by poor record keeping and said businesses providing such services should keep better records in case clients need to be contacted later.

    [ad_2]

    Source link

  • Study: ‘Little Evidence’ That Cannabis Harmfully Impacts Cognition in People with HIV | High Times

    Study: ‘Little Evidence’ That Cannabis Harmfully Impacts Cognition in People with HIV | High Times

    [ad_1]

    Cannabis is widely used to help mitigate the symptoms of a variety of conditions and diseases. Specifically, a number of state medical cannabis programs list HIV/AIDS as a qualifying condition, as cannabis can help to eliminate a variety of symptoms associated with HIV/AIDS treatment.

    Though, some clinicians have expressed concern how regular cannabis treatments in this regard may impact patient cognition. 

    Researchers affiliated with the University of California at San Diego sought to investigate the cognitive impacts of cannabis use in people with HIV through a newly published meta-analysis in the journal Current HIV/AIDS Reports

    Ultimately, they conclude that neither the use of whole-plant cannabis or cannabis-based medicines are associated with significant cognitive changes in those with HIV.

    Cannabis Use Among People with HIV

    In the study abstract, researchers note the potential benefits that cannabis use can offer patients with HIV while recognizing this population’s “high burden of persisting neurocognitive impairment” and physician concerns with adding cannabis into the mix, specifically its potential cognitive effects.

    Cannabis use among those with HIV is far from a new trend. The U.S. Food and Drug Administration first approved synthetic oral THC capsules (dronabinol) to treat HIV-induced cachexia, or loss of appetite, in 1985.

    Additionally, surveys have consistently affirmed that cannabis use is common among people with HIV, with one 2007 study predating the bulk of medical reform measures in the U.S. still finding that more than 60% of HIV/AIDS patients self-identified as medical cannabis users. 

    Another more recent 2022 study noted that 77% and 34% of people with HIV reported lifetime and past-year cannabis use, respectively.

    While some of these patients report recreational use as one reason, research over the years has found that cannabis is largely used among people with HIV to stimulate appetite, reduce pain, relax and ease anxiety and help with sleep.

    ‘Little Evidence’ of Harmful Cognitive Cannabis Impacts

    With plenty of existing data to pull from, researchers reviewed data from 34 clinical studies to determine the extent that cannabis impacts cognition among patients with HIV. The results, according to the study, revealed that there is “little evidence” to support that cannabis has a harmful impact on cognition among those with HIV.

    “Overall, the number of reported adverse effects were largely outnumbered by beneficial or null findings, providing insufficient support for the detrimental impact of CU [cannabis use] on cognition in PWH [people with HIV],” researchers reported, adding that the results suggest both cannabis and cannabis-based medications can be prescribed to people with HIV “while posing little threat to cognitive function.”

    The topic of cannabis use and cognition has seen a recent uptick in popularity, especially given recent conversations surrounding cannabis-induced psychosis (which has largely been linked to pre-existing conditions and vulnerabilities and is not a widespread issue among cannabis consumers, with some advocates arguing that the focus on this topic is a repackaged version of “Reefer Madness” propaganda from decades past).

    Of course, it’s important to look at the full picture and recognize how cannabis use and abuse may impact a variety of populations, and myriad studies attempt to look a bit more broadly at the topic.

    Recent research shows that cannabis users may actually have a lower chance of cognitive decline overall.  Previous studies have also noted links between heavy cannabis use and cognitive performance, though researchers noted that particular products used, methods of consumption and the reasons for use can also impact cognitive effects associated with cannabis use.

    Another recent study similarly found that adolescents who occasionally use cannabis do not see cognitive differences compared to those who abstain, once again highlighting a distinction surrounding frequency of use among other variables.

    [ad_2]

    Keegan Williams

    Source link

  • Stepping for a cause: 16 photos from AIDS Walk Arizona

    Stepping for a cause: 16 photos from AIDS Walk Arizona

    [ad_1]

    Hundreds of people sashayed, power-walked, jogged and ran their way to raising funds for HIV organizations across the state during the AIDS Walk Arizona & 5K on April 6. By Monday, the event had raised nearly $222,000 of its $250,000 goal, according to a fundraising tracker on its website…

    [ad_2]

    Kevin Hurley

    Source link

  • Hydeia Broadbent, who teamed up with Magic Johnson in HIV/AIDS fight, dies at 39

    Hydeia Broadbent, who teamed up with Magic Johnson in HIV/AIDS fight, dies at 39

    [ad_1]

    Hydeia Broadbent started speaking publicly about her experiences as someone with HIV/AIDS when she was a young child.

    “I want people to know that we’re just normal people,” a 7-year-old Broadbent told Magic Johnson during a Nickelodeon news special that aired in March 1992, four months after the Lakers superstar announced he was retiring from basketball because he was HIV-positive.

    Broadbent never stopped speaking out about the virus and disease — and Johnson thanked her for her courage.

    A leading activist in HIV/AIDS awareness, Broadbent, who was born with HIV, died Wednesday at age 39, her father said in a Facebook post. The cause of death was not specified.

    “With great sadness, I must inform you all that our beloved friend, mentor and daughter Hydeia, passed away today after living with AIDS since birth,” Loren Broadbent wrote. “Despite facing numerous challenges throughout her life, Hydeia remained determined to spread hope and positivity through education around HIV/AIDS.”

    Johnson took to X (formerly Twitter) on Wednesday to pay tribute to his longtime friend. His post included a video clip of their interaction on “Nick News with Linda Ellerbee” as well as photos of the two of them together in the years since then.

    AIDS Healthcare Foundation President Michael Weinstein, left, Hydeia Broadbent and Magic Johnson attend the premiere of ESPN Films’ “The Announcement” on March 6, 2011, in Los Angeles.

    (Joe Kohen / Associated Press Images For Aids Healthcare Foundation)

    “I’m devastated to hear about the passing of an incredible young woman, activist and hero Hydeia Broadbent,” Johnson wrote. “In 1992, I did a Nickelodeon special called ‘A Conversation with Magic’, and 7-year-old Hydeia and I made an incredible impact. Hydeia changed the world with her bravery, speaking about how living with HIV affected her life since birth. She dedicated her life to activism and became a change agent in the HIV/AIDS fight.

    “By speaking out at such a young age, she helped so many people, young and old, because she wasn’t afraid to share her story and allowed everyone to see that those living with HIV and AIDS were everyday people and should be treated with respect. Thanks to Hydeia, millions were educated, stigmas were broken, and attitudes about HIV/AIDs were changed. We will miss her powerful voice in this world. Cookie and I are praying for the Broadbent family and everyone that knew and loved Hydeia.”

    Broadbent was abandoned as a newborn at a Las Vegas hospital and adopted by her parents, Loren and Patricia, as an infant. They didn’t know that Broadbent was born with HIV until she got seriously ill at 3. At that age, she was diagnosed as HIV-positive, and two years later, the virus developed into AIDS. Her biological mother was an intravenous drug addict.

    Broadbent’s public speaking career began when she was 6. Soon after, in March 1992, Broadbent was one of 13 children who appeared with Johnson and Ellerbee on Nickelodeon after Johnson shocked the world with his HIV announcement in November 1991.

    Broadbent was one of two children who raised their hands when Ellerbe asked if any of them were HIV-positive. Her “normal people” comment was the only sentence she uttered during the program.

    Immediately after speaking, Broadbent started wiping away tears, then broke down sobbing. Johnson rubbed her back and spoke to her in a soothing tone.

    “You don’t have to cry,” he said. “‘Cause we are normal people. OK? We are. You just wanna be treated like that, right? You just want your friends to play with you? And call you up and come by and still have sleepovers and things like that? Right? Yeah. And it’s OK to cry, it’s OK to cry. You know, I think that you — with this program I feel that we’ll be able to educate all your friends and everybody else.”

    Broadbent would end up having plenty more to say over the next 32 years.

    At age 11, she told Oprah Winfrey the worst part of having HIV/AIDS was “when your friends die.” Speaking at the 1996 Republican National Convention, a 12-year-old Broadbent said, “I am the future, and I have AIDS.”

    Mary Fisher kisses 12-year-old Hydeia Broadbent as they were both addressing the evening session of the 1996 GOP convention

    AIDS activist Mary Fisher kisses 12-year-old Hydeia Broadbent as they address the evening session of the 1996 Republican National Convention in San Diego.

    (Ron Edmonds / Associated Press)

    Broadbent continued her advocacy as an adult — making appearances, doing interviews and giving lectures. She also worked with the AIDS Healthcare Foundation on several AIDS advocacy and awareness campaigns, riding on the foundation’s float in the 2013 Rose Parade and appearing in AHF’s “God Loves Me” billboard campaign.

    “I try to tell it as real as I can, that this isn’t a disease they want,” Broadbent told CNN in 2012. “The current generation, they don’t know the reality of HIV/AIDS. They look at me and Magic Johnson and think you can pop a pill and be OK. They don’t know the seriousness of the disease. They don’t know the side effects of the medicine. They don’t know the financial realities of the situation.

    “They really don’t know that you can die.”

    [ad_2]

    Chuck Schilken

    Source link

  • Fred Says Announces Annual Giving on World AIDS Day

    Fred Says Announces Annual Giving on World AIDS Day

    [ad_1]

    On Dec. 1, World AIDS Day, Fred Says announced it is giving nearly $200,000 to youth-serving organizations in the United States and around the world.

    Fred Says was founded in 2012 by Dr. Robert Garofalo and named after his dog Fred. The 501(c)(3) non-profit supports domestic and international organizations that serve LGBTQ youth and young people living with and/or impacted by HIV. 

    Dr. Garofalo is the Chief of the Division of Adolescent & Young Adult Medicine at Ann & Robert H. Lurie Children’s Hospital in Chicago and a Professor of Pediatrics at Northwestern University’s Feinberg School of Medicine. He adopted Fred following his own cancer and HIV diagnosis and created the non-profit to honor the joy, peace, and healing Fred brought to his life. 

    In 2023, Fred Says celebrated its 10th year of giving. To date, the organization has raised and distributed $1 million to support adolescents and young adults affected by HIV. 

    “It’s really rather amazing that on World AIDS Day, this little grassroots charity will celebrate a decade of charitable giving,” said Garofalo. “I hope these monies will help organizations provide the care and services that young people need to thrive and live their best authentic lives.”

    In sum, $190,000 will be gifted to 13 youth-serving organizations to support pet therapy and adoption programs, specialized mental health and drop-in services, transportation and housing assistance, peer-led support for HIV+ youth, and the development of educational materials about sexual health, wellness, and HIV-prevention, with an emphasis on minoritized transgender youth, their parents, and caregivers. 

    The 2023 Fred Says award recipients are:

    • Magic City Acceptance Academy, Birmingham, AL 
    • One Roof Chicago, Chicago, IL
    • Human Rights Campaign, Washington, D.C.
    • University of Ibadan, Ibadan, Nigeria
    • Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL
    • Lagos University Teaching Hospital, Lagos, Nigeria
    • Youth Outlook Services, Chicago, IL
    • Los Angeles Gay & Lesbian Center, Los Angeles, CA
    • Advocates for Youth, Washington, D.C.
    • Desmond Tutu Health Foundation, Cape Town, South Africa
    • Children’s Hospital of Philadelphia, Philadelphia, PA
    • VIVENT Health/TPAN, Chicago, IL
    • Initiative for the Advancement of Improved Health & Development, Ibadan, Nigeria

    Fred Says will also continue its tradition of distributing 500 Fred plush toys to children for the holidays in Chicago and Birmingham as well as in Nigeria and South Africa.

    “The generous gifts that Fred Says has given to us has ensured access to sexual and reproductive health services for young people who otherwise would not have had them,” said Linda-Gail Bekker, Chief Executive Office of the Desmond Tutu Health Foundation in Cape Town. “This is a wonderful investment in those young lives and in the future of South Africa.”

    You can learn more about Fred Says at www.fredsays.org. Contact: rgarofalo@luriechildrens.org

    Source: Fred Says

    [ad_2]

    Source link

  • Mark Clennon Takes Us Inside His Cinematic Debut

    Mark Clennon Takes Us Inside His Cinematic Debut

    [ad_1]

    Despite being a singer, songwriter, and saxophonist…Mark Clennon wants to give us more. Making his cinematic debut at the Toronto Film Festival, Clennon co-wrote I Don’t Know Who You Are alongside director M.H. Murray, and that’s not all. He also wrote the title track for the movie, incorporating his classic saxophone and mixing in a piano melody, his own lyrics, and the ultimate Mark Clennon touch.


    I Don’t Know Who You Are is gut-wrenching, following Benjamin, who is battling HIV (Human Immunodeficiency Virus) and experiencing the costliness of the disease. It’s not meant to be an easy watch, as both Murray and Clennon wanted to highlight the realities of HIV carriers, and how inaccessible necessary treatment and testing is.

    With over 39 million people who are HIV-positive in the United States, there is not nearly enough public knowledge on testing sites and life-saving medication. It’s more common than you’d think, and yet the topic remains taboo. I Don’t Know Who You Are is a valiant effort at both raising awareness for HIV and it’s carriers, as well as de-stigmatizing the virus in general.

    Alongside the film, Mark Clennon is the voice behind the title track: I Don’t Know Who You Are.” No stranger to the music business, Clennon can create a captivating track, and this is no exception. This single, just like the movie itself, is equal parts emotional and heartbreaking. You can listen to it here:

    Clennon went home after filming one day and says the song just “poured out of him.” With such a passionate project, the thought and effort is evident within. This won’t be the last you see of Mark Clennon in the cinema, and it most definitely isn’t the last time you’ll hear his music.

    We spoke exclusively to Mark Clennon about I Don’t Know Who You Are and the new single below!

    PD: “I Don’t Know Who You Are” was your cinematic debut, which you co-wrote with M.H. Murray. Can you tell us about your experience creating the film?

    Life changing! This film pushed me as an artist to places I never knew were possible and has left a lasting impact in how I view my work moving forward. The shoot itself was rewarding but very challenging but in a way that makes me a stronger, more resilient artist and human. Being on set felt familiar and safe just like making art with friends

    PD: What inspired you to get into the film industry?

    My whole life I’ve always been a very theatrical person and every time I’d watch television or a movie I would always imagine myself in the movie and it was a no brainer as I got older that i gravitated towards film and television

    PD: You’re bringing a lot of awareness towards ending the stigma against HIV carriers. What makes this cause important to you?

    I remember growing up in Jamaica and not knowing anything about HIV but having so much anxiety because of the stigma and misinformation around HIV. I would love to know that people of all walks of life have access to information and resources that could help to keep them safe and life fulfilling lives. I get tested every 3 months and something as simple as getting tested and knowing your status has made a tremendous impact on my life and I hope this movie brings us closer to a world where everyone is able to access the information and resources they need regarding sexual health

    PD: You also released the film’s title song, which addresses bringing awareness to HIV and other societal issues. After coming from a notoriously anti-LGBTQ+ country like Jamaica, did you find it difficult to speak out about these topics?

    Yes! It took me a long time to get to where i am today and it’s still a journey that I’m on but I’m so proud of who I am and the work that I do and to know that bringing representation to LGBTQ+ people in places like Jamaica is making a real impact in people lives is so fulfilling that it makes some of the challenges worth it

    PD: If you want viewers to take away one message from your film, what would it be?

    Be kind to everyone that you meet…Even when it’s hard.

    PD: What’s next for you in 2023?

    I’m in the final stages of my debut album and I have a few acting projects that I can’t speak about as of yet but when I can you’ll be the first to know.

    [ad_2]

    Jai Phillips

    Source link

  • CAN Community Health Names Terry Dyer as Director of Donor Development

    CAN Community Health Names Terry Dyer as Director of Donor Development

    [ad_1]

    Nationally renowned CAN Community Health (CAN) has named Terry Dyer as the Director of Donor Development. In this new role, Dyer will lead the charge to expand donor development and stewardship across CAN’s national markets which include Central and South Florida, Dallas/ Arlington, Texas, Phoenix, Arizona, Virginia, South Carolina, and recently Nevada. 

    “We are excited to have Terry join us at this pivotal moment of growth and development across the United States,” said Rogelio Capote, Senior Vice President, Chief Communications Officer. “We welcome his keen ability to establish new partnerships, engage donors who share our mission and to brand our successful model of healthcare.”

    Dyer has a solid history of working with Fortune 100 and 500 companies and nonprofit organizations to help reach their maximum potential and growth. His background consists of talent acquisition management, recruitment, client services and program management. Most recently, Dyer was the Executive Director of the World AIDS Museum and Education Center. During his tenure, he is credited with initiating fundraising efforts that raised more than $400,000. In addition, he established several impactful partnerships that resulted in innovative programming to end the stigma of HIV.

    Additionally, Dyer has volunteered his time to various organizations throughout the San Francisco Bay Area, Sacramento, Salt Lake City and South Florida communities. For several years, he served as a member of the San Francisco LGBTQ Speakers Bureau, which aimed to dispel homophobic and transphobic violence by educating people about the everyday lives of those in the community. In 2010, while working with STOP AIDS Project, POZ Health magazine named him “African American Person of the Month.”

    In July 2020, Dyer became the bestselling author of “Letters to a GAY BLACK BOY,” a memoir sparking conversations around racism, inequality, homophobia and more. Also in 2020, he was the recipient of the Kujichagulia Award for Self-Determination, presented at the Black Brothers Esteem (San Francisco AIDS Foundation) annual Kwanzaa event.

    In 2021, Dyer was presented the Ujima Men’s Collective Community Leadership Award and named by South Florida Gay News (SFGN) as 2021 Best New LGBT Activist. In 2022, he received SFGN’s nomination for Best LGBT Activist. During Black History Month 2023, Dyer received a proclamation from the City of Wilton Manors naming February 14th “Terry Dyer Day”. In May 2023, he was also recognized by the White House for his advocacy work. Currently, he is a board member of Plays of Wilton (POW) and is a member of the South Florida HRC Steering Committee. He also chairs the Black LGBTQ Planning Council.

    Dyer received his bachelor’s degree in vocal performance from Chico State University and a second degree in communications with an emphasis in public relations from Sacramento State University. He is a former All ­American collegiate volleyball player, a high school All-American track and field athlete, a competitive tennis player and a former contestant on the acclaimed TV show Star Search. 

    ABOUT CAN COMMUNITY HEALTH 

    CAN Community Health (CAN) is a not-for-profit, community-based organization with clinics in Florida, Arizona, New Jersey, South Carolina, Texas, and Virginia. CAN provides medical, pharmacy, dental, case management, mental health, and comprehensive prevention and services such as nPEP, PrEP, and education. CAN also provides screening and treatment for Viral Hepatitis, STDs and Gender Affirming Services. For more information about CAN Community Health and its services, please call (844) 922-2777 or visit www.cancommunityhealth.org. 

    Source: CAN Community Health

    Related Media

    [ad_2]

    Source link

  • Moderna is developing a Lyme disease vaccine in a first for the company

    Moderna is developing a Lyme disease vaccine in a first for the company

    [ad_1]

    Moderna Inc. said Tuesday it’s working to develop its first bacterial vaccine to protect against Lyme disease, the tick-borne illness that causes a range of painful symptoms, including fever, headaches, fatigue, joint pain and rash.

    The biotech
    MRNA,
    -2.75%
    ,
    whose first product to be approved by the U.S. Food and Drug Administration was its mRNA-based COVID vaccine, said it has two candidates in development to address Lyme disease, named mRNA-1982 and mRNA-1975.

    It announced the news at its fourth Vaccine Day, where it offered a full update on its clinical pipeline, which includes vaccines to protect against flu and respiratory syncytial virus, or RSV, as well as HIV, Epstein-Barr virus and herpes simplex virus, among others.

    There are about 120,000 cases of Lyme disease in the U.S. and Europe every year, creating a “significant quality of life burden,” the company said in a statement. Rising temperatures are helping the disease spread more easily, and it is difficult to diagnose, because the symptoms are similar to those of many other diseases. It most seriously affects children below the age of 15 and older adults.

    “Older adults appear to have higher odds of unfavorable treatment response as compared with younger patients, and neurologic manifestations are more common at presentation for this older adult population,” said the statement.

    Tick and Lyme disease season is here, and scientists warn this year could be worse than ever. Dr. Goudarz Molaei joins Lunch Break’s Tanya Rivero to explain what triggered the rapid spread of the disease and how people can avoid being affected. Photo: Kent Wood/Science Source

    The mRNA-1982 candidate is designed to create antibodies for Borrelia burgdorferi, the pathogen that causes almost all Lyme disease in the U.S., while mRNA-1975 is designed to elicit antibodies specific to the four major Borrelia species that cause the disease in the U.S. and Europe.

    Other new candidates in Moderna’s pipeline include mRNA-1405 and mRNA-1403, which aim to address the enteric virus norovirus. Norovirus is highly contagious and is the leading cause of diarrheal disease globally, Moderna said. It’s associated with about 18% of all such illnesses worldwide and causes about 200,000 deaths every year.

    Overall, Moderna is expecting to launch six major vaccine products in the next few years, all of them with large addressable markets.

    The company expects the annual global endemic market for COVID boosters alone to be worth about $15 billion.

    It has dosed the first participant in a late-stage trial of its next-generation, refrigerator-stable COVID-19 vaccine candidate, mRNA-1283. The vaccine “has demonstrated encouraging results in multiple clinical studies,” the company said.

    See now: Moderna CEO defends price increase for COVID vaccine to Congress

    A separate trial of a flu vaccine called mRNA-1010 fared less well, however.

    That trial “did not accrue sufficient cases at the interim efficacy analysis to declare early success in the Phase 3 Northern Hemisphere efficacy trial and the independent DSMB recommended continuation of efficacy follow-up,” the company said.

    The company expects the market for respiratory-product sales to range from $8 billion to $15 billion by 2027 and for operating profit that year to range from $4 billion to $9 billion.

    The stock was down 4% Tuesday and has fallen 15% in the year to date, while the S&P 500
    SPX,
    +0.17%

    has gained 7%.

    See also: Moderna’s stock slides as earnings fall short of estimates amid steep decline in COVID-vaccine sales

    [ad_2]

    Source link

  • ‘Morning After’ Antibiotics Could Slash Odds for Common STDs

    ‘Morning After’ Antibiotics Could Slash Odds for Common STDs

    [ad_1]

    By Amy Norton 

    HealthDay Reporter

    THURSDAY, April 6, 2023 (HealthDay News) — A “morning after” dose of a common antibiotic can greatly lower the chances of sexually transmitted bacterial infections in high-risk people, a new clinical trial has found.

    Researchers discovered that taking the antibiotic doxycycline within 72 hours of unprotected sex slashed the risk of gonorrhea, chlamydia and syphilis by two-thirds among gay and bisexual men and transgender women who either had HIV or were taking medication to help prevent HIV.

    The benefits at the one-year mark were considered so convincing that the trial was stopped early.

    Experts said the findings, published April 6 in the New England Journal of Medicine, showed that the approach to prevention is “highly effective.”

    And that’s needed at a time when sexually transmitted infections (STIs) are rising at a “scary” rate, said Dr. Colleen Kelley, an infectious disease specialist at Emory University in Atlanta, who was not involved in the trial.

    For the past decade, the United States has seen a worrying comeback in bacterial STIs that had previously been on the decline. The trend continued in 2020, a year marked by pandemic restrictions: 2.4 million Americans contracted chlamydia, gonorrhea or syphilis, according to the U.S. Centers for Disease Control and Prevention.

    And while that pattern cuts across demographics, men who have sex with other men have been disproportionately affected.

    The new trial focused on certain groups who are at particularly high risk of bacterial STIs: Gay and bisexual men, as well as transgender women, who either had HIV or were taking HIV PrEP (prescription medication that helps prevent HIV) and had been diagnosed with a bacterial STI in the past year.

    The researchers randomly assigned 500 participants to one of two groups: About two-thirds were given doxycycline and told to take a 200 milligram dose within 72 hours of unprotected sex; the rest stayed with their usual health care. All had STI testing done every three months.

    Over one year, participants using doxycycline were two-thirds less likely to be diagnosed with a bacterial STI. In that group, the incidence of STIs every three months was around 11% — versus over 30% in the comparison group.

    Preventive doxycycline was most effective against chlamydia and syphilis — cutting the risks of those infections by close to 90% in HIV-negative people, and by well over 70% in those with HIV. The efficacy against gonorrhea was less, but those infections were still cut by 55%.

    “It’s exciting to have another tool in the toolkit to prevent these infections,” said lead researcher Dr. Annie Luetkemeyer, a professor of medicine at the University of California, San Francisco.

    “We’ve tried relying on condom use,” she said. “But business as usual is not working.”

    That said, Luetkemeyer stressed that any STI preventive measure should be seen not as a magic bullet, but as “part of a package” — which may include condom use, frequent STI screening and vaccination against hepatitis B, for instance.

    Luetkemeyer underscored another point: The trial involved specific groups at high risk of bacterial STIs, and no one is saying that everyone should take doxycycline after having unprotected sex.

    One concern is that wider use of the antibiotic could increase bacterial resistance to doxycycline and other antibiotics in its class.

    But there has never been any documented resistance of syphilis or chlamydia to doxycycline, said Kelley, who is also vice chair of the HIV Medicine Association’s board.

    Some gonorrhea strains, however, are resistant to the antibiotic. And Kelley said it’s possible that with time, morning-after doxycycline will become less effective in preventing gonorrhea.

    On the positive side, both doctors said, doxycycline is not used to treat gonorrhea, so any increased resistance to the antibiotic should not hinder treatment of the STI.

    Another question is how will regular antibiotic use affect a person’s own microbiome (the collection of bacteria that naturally dwell in the body). That will require more research, Luetkemeyer said.

    But again, both doctors said, it’s a matter of “balance.” For people at such high risk of bacterial STIs — who would often be using antibiotics to treat them anyway — the benefits of preventive doxycycline could well outweigh the theoretical risk of altering the microbiome in a way that’s harmful, Kelley noted.

    At the moment, doxycycline is not routinely prescribed for STI prevention in high-risk individuals, Kelley said — though some city health departments (like San Francisco) and providers have embraced it.

    The U.S. Centers for Disease Control and Prevention, she noted, is expected to soon release some guidance on the subject.

    Luetkemeyer cautioned people against using doxycycline on their own by buying it online or using a friend’s prescription.

    “It’s always advisable to talk to a doctor and make sure this is right for you,” she said.

    And for now, at least, Luetkemeyer said she would not recommend that cisgender women use doxycycline for STI prevention, even if they are at high risk.

    This trial did not study cisgender (biological) women, but a recent trial in Kenya did and found that for young women using HIV PrEP, morning-after doxycycline did not cut the risk of bacterial STIs.

    The reasons, Luetkemeyer said, are unknown at this point.

    More information

    The U.S. Centers for Disease Control and Prevention has more on STD prevention.

     

    SOURCES: Annie Luetkemeyer, MD, professor, medicine, University of California, San Francisco; Colleen Kelley, MD, MPH, associate professor, medicine, Emory University School of Medicine, Atlanta, vice-chair, board of directors, HIV Medicine Association, Arlington, Va.; New England Journal of Medicine, April 6, 2023

    [ad_2]

    Source link

  • HIV Infections Could Spike After Ruling on Affordable Care Act: Experts

    HIV Infections Could Spike After Ruling on Affordable Care Act: Experts

    [ad_1]

    March 30, 2023 — A federal judge in Texas on Thursday struck down the preventive services mandate of the Affordable Care Act, ruling that the need to provide these services violated the religious rights of the plaintiffs. 

    One of the  plaintiffs who filed the lawsuit is  Steven Hotze, MD, a Texas doctor and conservative talk radio host. He said providing health insurance coverage for medication taken daily to prevent HIV to his employees would make him complicit in behaviors that he said violate his religious beliefs.

    The ruling applies nationwide, and public health experts were quick to criticize the decision. 

    “The human cost of this decision is very real,” said Meredithe McNamara, MD, an assistant professor of pediatrics and adolescent medicine specialist at Yale University. Yale researchers, anticipating the ruling, estimated in a recent study that eliminating coverage of the medication, known as PrEP (preexposure prophylaxis), which was mandated for health insurers under the Affordable Care Act, will result in at least 2,000 new HIV infections within a year.

    The two brand-name medications approved for PrEP, Truvada and Descovy, cost about $1,800 a month or more without insurance. Generic versions are available for less but are not always available, experts said. Other financial programs, including some by drugmakers, offer assistance to those who qualify. The mandate to provide PrEP coverage began in June 2020, after the U.S. Preventive Services Task Force (USPSTF), an independent panel of experts, gave it an “A” recommendation. Federal law requires any preventive services with an A or B to be covered.

    The ruling could also affect much more than just insurance coverage of PrEP. American Medical Association President Jack Resneck Jr., MD, in a statement, said the ACA required insurers and health plans to cover dozens of preventive health services with no cost to patients for things like early detection of cancer, hypertension, diabetes, and sexually transmitted infections. 

    “Millions of patients could lose first-dollar coverage for cholesterol treatment, tobacco and alcohol cessation, immunizations, and childhood screenings for lead poisoning, hearing loss, and autism,” he said. “Care that is critical to reducing maternal mortality would also be jeopardized. These preventive-care requirements that for 10 years have enabled millions of Americans to improve their health could just go away as a result of this flawed ruling.”

    “The government will surely appeal, and has every right to do so,” said Nicholas Bagley, a professor of law at the University of Michigan. “The big question is whether the courts will enter a stay, pending the appeal. I’d expect them to do so, but we will see.”

    Even without a stay, Bagley said, most insurance plans are annual, so coverage may not change right away, but that’s not certain. The ruling applies to preventive care guidelines issued after 2010, when the Affordable Care Act was enacted. The contraceptive mandate has been challenged in this case, Bagley said, but was rejected in September. He expects that decision to be appealed.   

    HIV Prevention: Key Strategy

    Prevention, including the use of PrEP, is a key strategy of the federal initiative Ending the HIV Epidemic in the U.S.  It aims to decrease new diagnoses to 3,000 by 2030. New diagnoses had decreased 8% from 2016 to 2019, according to the CDC, but there is work to be done to reach the 2030 goal. In 2020, there were 30,635 new HIV diagnoses. When taken correctly, PrEP reduces the risk of becoming infected by 99%, according to the CDC.

    In 2020, about 25% of the 1.2 million people in the U.S. for whom PrEP was recommended were actually prescribed it, up from about 3% in 2015, according to the CDC.

    One of those is Dan, a gay marketing professional in the Midwest who asked that his real name not be used. He has taken PrEP for about a decade. His employer’s health insurance plan covers it, and it’s important to him. 

    “I am sexually active, but not that much,” he said. Even so, he counts on the medication for protection when he is sexually active. If the coverage is taken away? “I would probably stop taking it,” he said.

    Yale Study and the Effect of Ending the Coverage

    Researchers from Yale University estimate that eliminating the PrEP coverage would result in at least 2,000 entirely preventable HIV infections in the following year, as PrEP usage declines without the mandated coverage. That estimate only takes into account the effect on men who have sex with men, not other people also at risk for HIV infection who could benefit from PrEP, such as those who inject drugs or women who have sex with an infected person.

    As a result, the estimate is very conservative, says study leader A. David Paltiel, PhD, a professor of health policy at the Yale School of Public Health. His team used U.S.-based data on HIV infection, current rates of PrEP coverage and effectiveness, and the estimated reduction in coverage if access to private health insurance benefits were curtailed.

    “We underestimated the number knocked out of PrEP coverage” if the repeal goes national, he said. Right now, about 28% of all men who have sex with men are getting coverage for PrEP, Paltiel estimates. “For every 1% drop from the 28%, there would be 114 new infections,” he said. The researchers also calculated that the percentage of people taking the drug would drop to about 10%. “If that happened, it will result in about 2,000 new infections in the following year. OK? There are people who are going to be left high and dry.”

    More on Braidwood Management v. Becerra

    In the lawsuit, Braidwood Management v. Becerra, several Christian-owned businesses and several people in Texas sued the federal government, saying the preventive services mandate violates their religious beliefs under the Religious Freedom Restoration Act, a 1993 federal law that guarantees interests in religious freedom are protected.

    The plaintiffs also argue that the Affordable Care Act requirement to provide recommended preventive services violates the Constitution’s Appointments Clause, which requires people the president appoints to positions be confirmed by the Senate. The Preventive Services Task Force members are instead appointed by the heads of agencies within the Health and Human Services Department.

    Since it was created in 1984, the task force has weighed in on numerous preventive measures, such as when to screen people for diseases and other questions, making evidence-based recommendations to help health care providers care for patients. 

    More Reactions

    In a statement, Bruce J. Packett, executive director of the American Academy of HIV Medicine, said the Yale report “highlights the critical necessity of taking into account public health repercussions of judicial decisions.”

    The effects of eliminating coverage could be catastrophic for HIV reduction efforts, he said. And, he pointed out, “the report only accounts for the effects of not requiring insurers to cover PrEP through one year; the authors did not calculate primary HIV transmissions that would happen well after a year and the secondary infections from those primary infections.”

    Also at risk, Packett said, is the authority of the Preventive Services Task Force. 

    “Striking down the USPSTF’s ability to recommend important evidence-based health care preventive services would be detrimental across the entirety of the public health goals of the United States,” he said. 

    The Braidwood Management case is “misreading science,” according to McNamara and other Yale researchers. In mid-February, they posted a report, explaining how the PrEP mandate promotes public health not for a segment of the population but the population as a whole. PrEP benefits public health, much like any vaccine or other preventive measure for avoiding infection.

    The researchers call PrEP “one of the most celebrated biomedical successes in the global fight to end the HIV epidemic.” 

    The harms of granting a nationwide injunction against requiring health insurance plans to cover PrEP would affect some ethnic groups disproportionately, McNamara said. Most affected, she said, would be Black and Latino gay and bisexual men, as well as transgender women.

    Younger at-risk people would also be at a disadvantage, said McNamara, who cares for adolescents in her clinic. “I can tell you that not having cost sharing for HIV prevention essentially means they aren’t going to use it at all,” she said.

    [ad_2]

    Source link

  • Scientists Get Closer to Understanding ‘Hidden’ HIV

    Scientists Get Closer to Understanding ‘Hidden’ HIV

    [ad_1]

    By Dennis Thompson 

    HealthDay Reporter

    WEDNESDAY, March 29, 2023 (HealthDay News) — Researchers are closing in on another immune system “hideout” that HIV uses to persist in the human body for years.

    A subset of white blood cells called myeloid cells can harbor HIV in people who’ve been virally suppressed for years, according to a new small-scale study funded by the U.S. National Institutes of Health (NIH).

    The researchers showed that HIV in specific myeloid cells can be reactivated, with the virus going on to infect new cells. These specific cells include short-lived monocytes and longer-lived monocyte-derived macrophages.

    The results suggest that myeloid cells contribute to a long-lived reservoir of HIV in those infected, researchers said.

    In that case, the white blood cells would be an important but overlooked target in efforts to eradicate HIV.

    “Our findings challenge the prevailing narrative that monocytes are too short-lived to be important in cure efforts,” said study author Rebecca Veenhuis, an assistant professor of molecular and comparative pathobiology and of neurology at Johns Hopkins University School of Medicine in Baltimore.

    “Yes, the cells are short-lived, but our follow-up data show that HIV can persist in monocytes over several years in people who are virally suppressed,” Veenhuis said in an NIH news release. “The fact that we can detect HIV in these cells over such a long period suggests something is keeping the myeloid reservoir going.”

    Antiretroviral drugs are effective in suppressing HIV, by preventing the virus from infecting new cells and multiplying.

    However, HIV already present in cells can remain dormant, creating an HIV reservoir that awaits the chance to spring back into action.

    CD4 T-cells, another type of white blood cell, are the most well-studied HIV reservoir, but researchers suspect others exist.

    Monocytes circulate in the blood for about three days before traveling to different tissues in the body, where they can mature into macrophages, researchers said. Up to now, it’s not been clear whether latent HIV in these cells can reactivate and infect other cells.

    “What’s really important in the long run is understanding how monocytes contribute to the tissue macrophage reservoir,” said senior study author Janice Clements, a professor of molecular and comparative pathobiology at Hopkins School of Medicine. “If monocytes can carry virus to the brain, or lung, or another part of the body and infect resident macrophages that are self-renewing and live almost indefinitely, that’s a real problem.”

    In the study, researchers measured HIV DNA in myeloid cells belonging to 30 patients infected with HIV, all of whom had been on antiretroviral therapy for at least five years.

    The team found detectable levels of HIV genetic material in monocytes and macrophages, although the levels were much lower than has been observed in CD4 T-cells.

    In some patients, the HIV genetic material found in monocytes was intact, suggesting it could reactivate and infect new cells.

    The researchers then used a new quantitative method to directly measure the viral spread of HIV found in myeloid cells.

    They isolated monocytes from the blood of 10 patients, and nurtured the cells in cultures that contained antiretroviral drugs, just like the patients.

    After the monocytes developed into macrophages, researchers introduced an agent that activates the immune system and then added fresh white blood cells to the cultures — giving the HIV a potential new target.

    Cultures of five of the 10 participants had detectable HIV genetic material in their macrophages that could be reactivated to infect other cells and replicate, researchers reported. Those patients also had higher overall levels of HIV DNA material.

    Follow-up data from three patients showed this reservoir can harbor latent HIV for up to several years. The reservoirs were stable and could be reactivated over time, indicating that monocyte-derived macrophages could contribute to HIV viral rebound if antiretroviral therapy is interrupted.

    The researchers called for larger studies with more diverse participant pools, to gain a better idea of how many people might carry latent HIV in myeloid cells and figure out how the monocyte HIV reservoir replenishes itself over time.

    The study was published March 27 in the journal Nature Microbiology.

    More information

    The U.S. National Institutes of Health has more about the latent HIV reservoir.

     

    SOURCE: U.S. National Institutes of Health, news release, March 27, 2023

    [ad_2]

    Source link